Fit
Name the client, the population and who decides. LYF ships as access, not boxes: no inventory, no returns, no batteries to replace.
RespireLYFTMLive Your FullestFor pharma, care-management & distribution partners
Bring a breathing co-pilot to the people you already serve.Ship nothing.
The people you already serve get a co-pilot that counts the coughs they slept through, logs and coaches their inhaler from a compatible smartwatch, reads ten everyday factors and checks what each step did—on the phone they already own. Your program gets the month they lived, before the next contact. Start with one client or population.
- No smart inhalers to buy.
- No clip-on sensors to ship or recover.
- Patent-protected.
A partner's program at the centre, and around it the people it already serves, each with the phone they already own. The co-pilot reaches each of them as access, a thread of light to their phone, while the counts of boxes shipped, returns and batteries replaced stay at zero.
Care management · nurse networks · distribution · patient organizations
Your nurse calls once a month. LYF is there the other twenty-nine days.
Between your contacts, members get personal breathing insights, timely coaching and help keeping the routines that work. Support for better breathing every day—and patterns, steps and progress for the next nurse conversation, in one report.
Scope
Map enrollment, participant support, clinical responsibilities and data requirements. Agree the report exports and any integration before launch.
Launch
Agree the first cohort, launch responsibilities and success measures. Use participation, feedback and support requirements to decide where to expand.
Distributors
Give the people using your inhalers, spacers and peak-flow meters personal breathing support between visits. Add LYF’s guidance, inhaler coaching and progress reports to your offering—nothing new to warehouse, ship or recover.
Patient organizations
Give your community daily support between the newsletter and the clinic: coughs counted at night, a Breathing Fingerprint, one small step at a time—and eleven white papers to read with no email wall. You bring the members; we agree the access route together.
From daily support to the next conversation
Their month. Their patterns.Something useful to bring back.
Cough and inhaler trends, the steps they tried and what changed—together in a report they can share.
Your nurses read the month before the call: cough nights, inhaler use and technique, the steps tried and what followed. How it reaches them—shared report, export or staff access—is set for your service before launch.
Respire LYF · Monthly reportApril 2026PDFYour month
MTWTFSS123456789101112131415161718192021222324252627282930
- Stronger days 15
- In between 10
- Tougher days 5
Cough Rose 9–14 April
Reliever inhaler 6 → 2 puffs a week
3642
Prescribed inhaler · taken 28 of 30 days
On your better days
- Dinner before 8 pm12 of 15
- Breathing exercise before work10 of 15
- Windows shut when pollen peaks7 of 15
Chronic care is moving between visits
Care organizations: build your COPD program for life between visits.
CMS announced on 15 September 2026 that its ACCESS model will expand to COPD in spring 2027. The care organizations ready for it will be the ones whose members already have a daily co-pilot.
Start the first COPD cohort now: cough and inhaler use captured every day, one step at a time, and a month your nurses read before the call. (Participation, payment eligibility and clinical responsibilities depend on the organization and agreed service; the announcement is not an approval or endorsement of Respire LYF.)
Pharma & patient-support programs
An inhaler record should show more than a dose taken.
A counted dose is not a well-taken dose. In a 2016 review of inhaler use—144 studies, 54,354 people—only 31% used their inhaler correctly. Respire LYF logs use and coaches technique from a compatible smartwatch, with nothing on the inhaler—pressurized metered-dose inhalers used without a spacer today—and connects both to each patient’s everyday patterns. A technique view your program has never had, without a device to supply.
Works with the pressurized metered-dose inhaler your patients already hold, from day one—no sensor to co-develop, no device to supply, no kit to recover. Dry-powder brands start with the phone co-pilot: cough counted, doses logged by one tap or voice, patterns and everyday coaching. Bring the brand, the patient group and the question; leave with a scoped evaluation.
Research & health-system partners
Test the benefit that matters to your patients.
Bring your patient group and the outcome you want to understand. Build the evaluation around their experience and your next decision: delivery feasibility, participant experience or a defined clinical research question.
One connected platform
Not a tracker. Not a dashboard.A co-pilot.
Less logging.
Automatic cough capture, watch measurements, local conditions and connected peak-flow readings.
Personal help.
Your Breathing Fingerprint, food guidance, inhaler coaching, nudges and guided breathing exercises.
Better habits. Visible progress.
See what changed after an action. Build on what helps. Share a report at the next care conversation.
The phone is the co-pilot. A compatible smartwatch adds automatic inhaler logging and live technique coaching.
One first cohort.Nothing to ship.
Tell us the population you serve and the support you already provide. Leave with a scoped first program.